AMENDMENT #1 TO CLINICAL STUDY AGREEMENTClinical Study Agreement • February 20th, 2020 • Volitionrx LTD • In vitro & in vivo diagnostic substances
The following is Amendment #1 to the Clinical Study Agreement dated July 17, 2017 between Volition America, Inc. (“Laboratory”) and the Regents of the University of Michigan (the “University”) for Dean Brenner, ORSP Reference # AWD005981, and incorporates all of the terms therein. This Amendment is effective as of September 1, 2019.
